SAFETY AND EFFICACY OF ERYTHROPOIETIN IN AMYOTROPHIC LATERAL SCLEROSIS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Registry ID

EUCTR2009-016066-91

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

ISTITUTO NEUROLOGICO "CARLO BESTA"

Start date

2010-03-10

Last update

2026-08-16

Conditions

• ALS

Summary

Confirm safety and tolerability of rhEPO administration over 18 months

Locations

• , , Italy

Related clinical trials

• Using the EHR to Advance Genomic Medicine Across a Diverse Health System
• Multicenter ALS Imaging Study
• PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
• Neurologic Stem Cell Treatment Study
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
• ALS/MND Natural History Study Data Repository

View on source registry